Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Tighiouart, Mourad

Cedars-Sinai Medical Center
United States

Advancing Analysis and Interpretation of Adverse Events and PROs in Cancer Clinical Trials 3U01CA232859-05S1 Rachel Altshuler, Ph.D.
Tollefsbol, Trygve O

University Of Alabama At Birmingham
United States

Combinatorial epigenetic-based prevention of breast cancer 5R01CA178441-09 Gabriela Riscuta, M.D., CNS
Toriola, Adetunji T

Washington University
United States

Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention 4R37CA235602-06 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Torres, Keila Enitt

University Of Tx Md Anderson Can Ctr
United States

Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs 1R01CA285980-01 Richard Mazurchuk, Ph.D.
Trimble, Cornelia L

Johns Hopkins University
United States

Immunomodulatory effects of topical artesunate on cervical intraepithelial neoplasia 2/3. 5R21CA263256-02 PAR-20-292 (R21 Clinical Trial Optional) Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Tussing-Humphreys, Lisa

University Of Illinois At Chicago
United States

Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity 3R01CA257807-04S1 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Ulrich, Cornelia M

University Of Utah
United States

Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link 5R01CA254108-04 Asad Umar, D.V.M., Ph.D.
V, DHODAPKAR, MADHAV

EMORY UNIVERSITY
United States

Targeting microbial triggers of gammopathy for immunoprevention 1UG3CA290302-01
Valdez, Erin G

Stanford University
United States

Circadian regulation of cancer therapy-associated neuroinflammation 5R21CA267135-02 Marge Good, RN, M.P.H., OCN
Valdimarsdottir, Heiddis

Icahn School Of Medicine At Mount Sinai
United States

Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation 5R01CA260961-03 PAR-21-035 (R01 Clinical Trial Required) Marge Good, RN, M.P.H., OCN